A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer

NCT03473743 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Urothelial Carcinoma

Interventions

DRUG: Erdafitinib
DRUG: Cetrelimab
DRUG: Cisplatin
DRUG: Carboplatin

Sponsor

Janssen Research & Development, LLC